Pneumonia due to other infectious organisms, not elsewhere classified

J10_PNEUMONONBACT

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 J16|J17[2-8]
  • Hospital discharge: ICD-9 483
  • Hospital discharge: ICD-8 48399
  • Cause of death: ICD-10 J16|J17[2-8]
  • Cause of death: ICD-9 483
  • Cause of death: ICD-8 48399

2 out of 7 registries used, show all original rules.

1316

4. Check minimum number of events

None

1316

5. Include endpoints

None

1316

6. Filter based on genotype QC (FinnGen only)

1280

Control definitions (FinnGen only)

Control exclude
J10_INFLUPNEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9869 4313 5437
Only index persons 7295 3334 3961
Unadjusted period prevalence (%)
Whole population 0.14 0.12 0.15
Only index persons 0.14 0.12 0.15
Median age at first event (years)
Whole population 55.32 52.82 57.02
Only index persons 43.09 42.06 43.96

-FinnGen-

Key figures

All Female Male
Number of individuals 1280 608 672
Unadjusted period prevalence (%) 0.26 0.22 0.31
Median age at first event (years) 59.07 53.23 64.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1316
Matched controls
13160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UGC12
NOMESCO Finland
Flexible bronchoscopy
15.2
307.7
386
350
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
307.7
564
*
TGC00
NOMESCO Finland
Bronchial lavation
55.8
307.7
322
76
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
98.6
307.7
255
32
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
20.0
307.7
316
205
J18.9
ICD-10 Finland
Pneumonia, unspecified
43.8
307.7
734
368
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
+∞
217.9
203
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.3
217.0
234
228
R50.9
ICD-10 Finland
Fever, unspecified
6.5
207.1
434
923
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.1
205.2
257
308
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.7
203.5
337
563
ZX108
NOMESCO Finland
Inhalation
70.5
179.9
98
15
48399
ICD-8 Finland
Pneumonia due to other specified organism
+∞
163.0
153
*
J01MA14
ATC
moxifloxacin; systemic
8.1
159.3
238
350
GD1AD
NOMESCO Finland
Thorax CT examination
9.0
154.1
207
268
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.4
153.5
295
565
4830A
ICD-9 Finland
Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA E MYCOPLASMA PNEUMONIAE]
+∞
148.8
140
*
XW000
NOMESCO Finland
Bone marrow biopsy
9.9
144.0
177
204
H02AB06
ATC
prednisolone; systemic
4.3
142.9
872
4103
WW500
NOMESCO Finland
Blood transfusion
10.2
138.6
165
182
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
17.7
133.5
111
68
ZX120
NOMESCO Finland
Intravenous
6.1
131.1
263
521
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
7.1
129.3
216
356
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
37.8
120.7
75
21
L03AA02
ATC
filgrastim; parenteral
10.9
120.1
135
137
JN4AD
NOMESCO Finland
Body CT examination
5.3
120.0
287
663
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.4
116.6
365
1046
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.5
115.6
144
168
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
115.1
810
3995
J01MA12
ATC
levofloxacin; systemic
4.1
107.6
382
1194
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
11.2
105.0
115
112
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.3
103.8
164
253
J16.0
ICD-10 Finland
Chlamydial pneumonia
+∞
101.4
96
*
L04AA06
ATC
mycophenolic acid; systemic
15.9
100.7
88
59
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
17.7
100.3
83
50
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.9
90.7
108
118
C03CA01
ATC
furosemide; systemic
3.2
86.3
520
2240
JN4BD
NOMESCO Finland
Extensive body CT
4.5
85.8
244
639
4830X
ICD-9 Finland
Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA ALIA DEFINITA]
+∞
82.1
78
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.5
81.5
109
138
127
Kela drug reimbursment
Transplant complication
15.6
80.7
71
48
D70.82
ICD-10 Finland
Drug-induced neutropenia
12.6
80.4
80
67
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
30.6
80.2
53
18
A04AA01
ATC
ondansetron; systemic, rectal
4.8
78.9
200
477
L04AX01
ATC
azathioprine; systemic
7.0
78.7
127
199
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.7
78.4
205
501
H02AB02
ATC
dexamethasone; systemic
4.0
77.5
257
751
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
77.2
158
313
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
25.6
76.8
54
22
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.7
75.0
126
206
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
72.9
408
1659
Z51.5
ICD-10 Finland
Palliative care
4.6
70.4
184
448
R81
ICPC
Pneumonia
9.7
70.2
84
92
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.2
70.1
71
61
M04AA01
ATC
allopurinol; systemic
3.5
68.3
280
939
L03AA13
ATC
pegfilgrastim; parenteral
6.0
67.9
126
227
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
66.7
533
2605
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
65.6
294
1041
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.5
63.9
130
255
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
61.6
254
851
J01FF01
ATC
clindamycin; systemic
2.7
61.2
463
2183
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
15.7
60.8
53
35
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.6
60.7
89
125
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
10.6
59.4
66
65
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.7
57.9
142
327
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
57.8
374
1620
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.6
57.3
52
37
L04AD01
ATC
ciclosporin; systemic
9.9
55.5
65
69
R06.0
ICD-10 Finland
Dyspnoea
2.6
55.2
431
2047
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.5
55.1
215
693
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
10.1
53.1
61
63
TK800
NOMESCO Finland
Hemodialysis
8.6
52.1
68
83
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.3
51.2
47
34
N02AA05
ATC
oxycodone; systemic
2.8
50.9
309
1284
A04AA02
ATC
granisetron; systemic, transdermal
4.2
50.2
146
383
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.1
49.7
48
38
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
15.1
49.5
44
30
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.8
49.3
94
173
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
47.4
736
4672
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.8
47.3
294
1233
A41.9
ICD-10 Finland
Sepsis, unspecified
6.1
47.2
85
148
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
6.4
44.7
76
125
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.5
44.4
74
119
JN6AD
NOMESCO Finland
CT of torso and neck
8.3
44.2
59
74
H02AB09
ATC
hydrocortisone; systemic
7.0
44.0
68
101
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
+∞
44.0
42
*
L04AA01
ATC
[U] ciclosporin
11.3
43.5
46
42
R03AC02
ATC
salbutamol; inhalant
2.2
43.2
753
4942
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.5
42.8
111
266
ZX112
NOMESCO Finland
Subcutaneous
7.3
42.7
64
92
A07AA09
ATC
vancomycin; oral
11.6
42.4
44
39
R03BB04
ATC
tiotropium bromide; inhalant
3.4
42.3
166
533
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.4
42.1
112
274
1XC02, ,
NOMESCO Finland
17.1
42.0
35
21
A02BC02
ATC
pantoprazole; systemic
2.3
41.4
943
6846
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
41.3
280
1219
J96.0
ICD-10 Finland
Acute respiratory failure
13.9
40.9
38
28
Z94.0
ICD-10 Finland
Kidney transplant status
11.7
40.6
42
37
L04AD02
ATC
tacrolimus; systemic
12.9
40.2
39
31
WZC00
NOMESCO Finland
Treatment plan or consultation
2.2
39.8
532
3113
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.6
39.8
290
1306
H02AB07
ATC
prednisone; oral
2.8
38.7
224
898
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.2
38.4
107
271
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.2
38.2
47
53
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.3
37.8
65
108
L01BA01
ATC
methotrexate; systemic
5.2
37.7
80
162
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
37.0
104
265
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.6
36.9
60
94
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
36.6
35
*
B03XA01
ATC
erythropoietin; parenteral
11.5
36.3
38
34
J05AB11
ATC
valaciclovir; oral
2.6
36.3
245
1059
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
45.4
36.1
44
10
L03AA14
ATC
lipegfilgrastim; parenteral
6.7
36.0
58
90
B59
ICD-10 Finland
Pneumocystosis
190.2
35.9
37
*
B03XA02
ATC
darbepoetin alfa; parenteral
6.8
35.9
57
87
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.8
35.4
45
53
J02AC03
ATC
voriconazole; systemic
126.8
34.9
37
*
WX892
NOMESCO Finland
Monitored bed care
3.4
34.6
137
441
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.4
34.5
58
94
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.5
34.3
124
376
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
13.0
34.1
33
26
XG410
NOMESCO Finland
Flow-volume spirometry
4.9
33.7
77
166
L04AX03
ATC
methotrexate; systemic
2.9
33.2
167
618
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
33.1
427
2429
H02AB04
ATC
methylprednisolone; systemic
2.6
32.9
223
963
I50.9
ICD-10 Finland
Heart failure, unspecified
2.7
32.9
194
782
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
12.6
32.5
32
26
48609
ICD-8 Finland
Pneumonia, unspecified
+∞
32.4
31
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
32.2
179
699
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
32.0
138
467
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.1
31.2
67
137
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
30.8
181
727
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.1
30.0
64
130
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.3
30.0
121
393
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.0
29.9
41
53
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
29.2
186
777
WX882
NOMESCO Finland
High dependency care
5.6
28.8
55
101
M05BX04
ATC
denosumab; parenteral
3.5
28.6
103
311
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.8
28.6
40
53
WW200
NOMESCO Finland
Immunization
5.4
28.3
57
110
J12.8
ICD-10 Finland
Other viral pneumonia
+∞
28.2
27
*
B01AB10
ATC
tinzaparin; parenteral
2.7
28.2
164
654
J46
ICD-10 Finland
Status asthmaticus
6.3
28.1
48
79
A07EC01
ATC
sulfasalazine; oral, rectal
2.9
27.8
137
500
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
27.8
147
558
J96.1
ICD-10 Finland
Chronic respiratory failure
8.0
27.8
38
49
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.2
27.5
31
31
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
27.3
169
695
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.9
27.2
49
85
J47
ICD-10 Finland
Bronchiectasis
7.6
27.2
39
53
J01FA06
ATC
roxithromycin; oral
1.9
27.2
522
3366
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.6
27.1
32
34
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.9
27.1
61
130
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.3
26.9
107
344
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
42.2
26.9
33
8
A03
ICPC
Fever
2.3
26.8
226
1072
A46
ICD-10 Finland
Erysipelas
2.4
26.7
213
986
1CX01, ,
NOMESCO Finland
142.9
26.7
28
*
A12AA04
ATC
calcium carbonate; oral
6.6
26.6
43
67
Z2446
NOMESCO Finland
Social worker
3.3
26.4
107
348
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
26.3
176
751
A10AB05
ATC
insulin aspart; parenteral
3.0
26.3
124
441
P01BA02
ATC
hydroxychloroquine; oral
2.9
26.3
130
475
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
26.2
345
1951
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.1
26.0
32
36
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
25.9
177
763
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
5.5
25.9
50
93
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.3
25.5
68
166
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.7
25.0
47
85
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
10.2
24.8
28
28
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.8
24.8
39
59
A11CC03
ATC
alfacalcidol; systemic
5.1
24.6
52
105
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
24.9
24.4
34
14
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
7.0
24.3
37
54
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.4
24.2
62
147
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
24.0
23
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
5.9
23.8
43
75
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
8.3
23.6
31
38
WW300
NOMESCO Finland
Transfer of autologic stem cells
24.1
23.5
33
14
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.6
23.5
56
125
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
23.5
484
3158
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
34.1
23.4
30
9
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.4
23.4
186
858
SPAT1255
SPAT
Intravenous administration of medicine
3.1
23.3
103
353
WF004
NOMESCO Finland
Palliative radiotherapy
5.8
22.2
41
73
B01AB05
ATC
enoxaparin; parenteral
1.9
22.1
414
2612
M01CB01
ATC
sodium aurothiomalate; parenteral
7.2
22.1
33
47
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.0
21.9
101
354
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
4.9
21.9
49
104
J01MA02
ATC
ciprofloxacin; systemic
1.8
21.8
515
3483
J16
ICD-10 Finland
Pneumonia due to other infectious organisms, not elsewhere classified
223.6
21.7
22
*
ZXD05
NOMESCO Finland
Urgent procedure
1.8
21.5
405
2558
J01DB01
ATC
cefalexin; oral
2.0
21.4
1065
8944
I50.0
ICD-10 Finland
Congestive heart failure
3.1
21.4
95
326
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
21.0
147
639
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.7
20.9
120
474
C90.0
ICD-10 Finland
Multiple myeloma
7.8
20.9
29
38
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
20.9
583
4124
ZX100
NOMESCO Finland
Oral
7.2
20.8
31
44
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
20.8
540
3739
AA1AD
NOMESCO Finland
CT of head and brain
1.9
20.8
356
2177
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
20.7
98
349
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
213.2
20.6
21
*
N03AX16
ATC
[U] pregabalin
1.9
20.6
304
1770
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
20.3
144
629
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.5
20.2
26
31
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
20.1
141
613
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
20.0
125
514
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.9
20.0
60
160
N02AX02
ATC
tramadol; systemic, rectal
1.7
20.0
562
3968
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
20.0
219
1147
R03AK07
ATC
formoterol and budesonide; inhalant
2.0
19.9
263
1473
WZC30
NOMESCO Finland
Teaching
2.1
19.9
225
1192
J01CA04
ATC
amoxicillin; systemic
1.9
19.9
1032
8648
L04AA13
ATC
[U] leflunomide
4.4
19.6
49
114
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
40.7
19.5
24
6
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.2
19.4
33
54
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
19.4
210
1093
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
19.3
222
1183
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.0
19.2
241
1325
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.3
19.2
39
76
RD210, ,
NOMESCO Finland
5.9
18.9
34
59
B48.5
ICD-10 Finland
Pneumocystosis
+∞
18.8
18
*
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
+∞
18.8
18
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.1
18.7
52
131
ZXE00
NOMESCO Finland
One hour or less
1.7
18.7
500
3465
J05AB01
ATC
aciclovir; systemic
1.9
18.7
294
1743
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
18.7
341
2118
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.4
18.4
46
107
J01AA02
ATC
doxycycline; systemic
1.8
18.4
983
8188
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.7
18.3
60
170
L04AB04
ATC
adalimumab; parenteral
4.6
18.3
44
99
N18.0
ICD-10 Finland
End-stage renal disease
7.2
18.3
27
38
N05CF01
ATC
zopiclone; oral
1.8
18.2
404
2653
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
18.1
87
312
PJA10
NOMESCO Finland
Exploration of lymph nodes
5.9
18.0
32
55
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
18.0
92
342
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.0
17.9
51
131
R02
ICPC
Shortness of breath/dyspnoea
2.2
17.9
169
834
J17.2*B44.1
ICD-10 Finland
Pneumonia in other aspergillosis
+∞
17.7
17
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
17.7
53
141
R05
ICD-10 Finland
Cough
1.9
17.7
271
1589
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
17.7
289
1731
A10AC01
ATC
insulin (human); parenteral
2.5
17.6
114
477
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.1
17.4
30
50
WX725
NOMESCO Finland
Noninvasive ventilation
2.9
17.3
82
292
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
17.2
372
2419
E87.5
ICD-10 Finland
Hyperkalaemia
5.6
17.0
32
58
390
Kela drug reimbursment
Ibrutinib
64.2
16.8
19
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
16.8
46
115
J17.2*B44.0
ICD-10 Finland
Pneumonia in invasive aspergillosis
+∞
16.7
16
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.9
16.7
37
78
E0000UV, ,
ATC
1.7
16.6
513
3663
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
16.6
243
1402
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
91.2
16.6
18
*
R06AE07
ATC
cetirizine; oral
1.6
16.5
528
3802
C83.1
ICD-10 Finland
Mantle cell lymphoma
18.2
16.5
25
14
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
16.4
253
1483
Z3231
NOMESCO Finland
Registered nurse
1.7
16.4
345
2221
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
5.8
16.4
30
53
R03BA02
ATC
budesonide; inhalant
1.9
16.2
219
1229
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.2
16.0
33
65
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
48.1
16.0
19
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
13.8
16.0
27
20
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.0
16.0
34
69
UJF32
NOMESCO Finland
Coloscopy
1.7
15.9
336
2165
R03BA08
ATC
ciclesonide; inhalant
2.4
15.8
115
508
B34.9
ICD-10 Finland
Viral infection, unspecified
4.0
15.7
45
116
N02BE01
ATC
paracetamol; systemic, rectal
2.0
15.7
1136
10041
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
+∞
15.7
15
*
L01BB05
ATC
fludarabine; systemic
+∞
15.7
15
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
15.6
87
338
WX726
NOMESCO Finland
High-flow oxygen therapy
86.1
15.6
17
*
212
Kela drug reimbursment
Gout
4.4
15.5
39
91
A06AD11
ATC
lactulose; oral
2.0
15.5
184
987
J15.8
ICD-10 Finland
Other bacterial pneumonia
161.9
15.5
16
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
38.5
15.4
19
5
49300
ICD-8 Finland
Asthma, bronchiale
4.4
15.3
38
88
A41.8
ICD-10 Finland
Other specified sepsis
5.0
15.3
33
68
R04.2
ICD-10 Finland
Haemoptysis
3.5
15.2
52
152
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.4
15.2
30
57
R28
ICPC
Limited function/disability (R)
6.1
15.2
26
43
R03BA05
ATC
fluticasone; inhalant
1.9
15.1
217
1241
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.4
15.0
25
40
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
14.9
66
226
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
14.9
65
221
A04AA55
ATC
palonosetron, combinations; systemic
3.2
14.8
60
195
1512
Kela drug reimbursment
Ibrutinib
57.3
14.8
17
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.5
14.8
51
150
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.4
14.7
29
55
C07AB07
ATC
bisoprolol; oral
1.6
14.7
602
4569
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
81.0
14.6
16
*
WX002
NOMESCO Finland
Sedation and analgesia
1.8
14.5
253
1537
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.3
14.4
29
56
R03BA01
ATC
beclometasone; inhalant
2.0
14.4
170
910
A07AA02
ATC
nystatin; oral
2.7
14.4
79
305
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.0
14.3
41
106
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
22.5
14.2
20
9
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.1
14.2
61
206
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
14.1
284
1796
J20
ICD-10 Finland
Acute bronchitis
2.2
14.1
130
633
J01FA10
ATC
azithromycin; systemic
1.6
14.1
679
5328
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.7
14.0
75
286
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
20.3
13.8
20
10
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.8
13.7
42
114
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
13.6
175
964
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.8
13.6
41
110
WX720
NOMESCO Finland
Own respiration
2.6
13.6
78
308
R53
ICD-10 Finland
Malaise and fatigue
1.7
13.6
282
1799
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.9
13.4
62
218
L04AB01
ATC
etanercept; parenteral
4.9
13.4
29
60
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.9
13.4
29
60
R03AK08
ATC
formoterol and beclometasone; inhalant
3.0
13.3
58
197
137
Kela drug reimbursment
Uraemia requiring dialysis
6.4
13.3
22
35
R4110
NOMESCO Finland
Physiotherapy
1.7
13.3
338
2273
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.2
13.3
52
166
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
13.2
84
348
N17.8
ICD-10 Finland
Other acute renal failure
6.0
13.1
23
39
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.1
12.9
35
87
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.8
12.8
38
101
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.1
12.7
54
181
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.7
426
3059
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
12.7
164
904
L88
ICPC
Rheumatoid/seropositive arthritis
3.0
12.6
56
193
A02BC01
ATC
omeprazole; systemic
1.6
12.5
329
2226
48509
ICD-8 Finland
Bronchopneumonia, unspecified
+∞
12.5
12
*
JN4CD
NOMESCO Finland
Very extensive body CT
2.9
12.5
57
199
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
12.5
73
291
Z94.2
ICD-10 Finland
Lung transplant status
131.2
12.5
13
*
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
131.2
12.5
13
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
13.3
12.4
21
16
RS220, ,
NOMESCO Finland
5.7
12.4
23
41
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
11.8
12.3
22
19
SPAT1262
SPAT
Handing over of treatment supplies
1.8
12.3
223
1365
B02.9
ICD-10 Finland
Zoster without complication
2.3
12.3
96
437
N05BA04
ATC
oxazepam; oral
1.6
12.3
307
2050
Z3226
NOMESCO Finland
Physiotherapist
1.8
12.2
221
1352
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.2
538
4097
153
Kela drug reimbursment
Lenalidomid
12.5
12.1
21
17
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
12.1
59
214
L01AA02
ATC
chlorambucil; oral
18.2
12.1
18
10
SPAT1263
SPAT
Sampling
1.5
12.1
497
3728
6BA02, ,
NOMESCO Finland
27.0
12.1
16
6
399
Kela drug reimbursment
Venetoclax
27.0
12.1
16
6
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
12.0
79
333
WW409
NOMESCO Finland
Other aferesis
21.5
12.0
17
8
M05BA04
ATC
alendronic acid; oral
2.2
12.0
101
475
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
4.1
11.9
32
79
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
11.9
172
984
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
11.9
45
141
V03AE01
ATC
polystyrene sulfonate; oral
5.4
11.8
23
43
J18
ICD-10 Finland
Pneumonia, organism unspecified
9.7
11.8
23
24
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
9.7
11.8
23
24
R11
ICD-10 Finland
Nausea and vomiting
2.2
11.7
107
519
J01FA09
ATC
clarithromycin; systemic
1.6
11.7
360
2524
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
16.6
11.7
18
11
N19
ICD-10 Finland
Unspecified kidney failure
3.0
11.7
51
174
YNB10
NOMESCO Finland
Collection of stem cells for transplant
30.3
11.7
15
5
WX402
NOMESCO Finland
General anaesthesia
1.7
11.6
257
1661
L01AA01
ATC
cyclophosphamide; systemic
19.1
11.6
17
9
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
11.5
89
404
D07AC01
ATC
betamethasone; topical
1.5
11.5
439
3232
J02AC05
ATC
isavuconazole; systemic
+∞
11.5
11
*
J17.2*B37.1
ICD-10 Finland
Pneumonia in candidiasis
+∞
11.5
11
*
J94.8
ICD-10 Finland
Other specified pleural conditions
4.9
11.5
25
52
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
11.4
104
504
L01XE27
ATC
[U] ibrutinib
121.0
11.4
12
*
R03AC12
ATC
salmeterol; inhalant
2.9
11.4
53
187
J02AC01
ATC
fluconazole; systemic
1.5
11.4
428
3137
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.2
11.3
23
45
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.9
11.2
51
178
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
11.2
68
276
RS221, ,
NOMESCO Finland
4.8
11.2
25
53
R03DC03
ATC
montelukast; oral
1.8
11.2
183
1085
WX704
NOMESCO Finland
Intubation
2.2
11.2
101
488
L04AX04
ATC
lenalidomide; oral
12.8
11.1
19
15
1518, ,
Kela drug reimbursment
25.3
11.1
15
6
D69.5
ICD-10 Finland
Secondary thrombocytopenia
20.2
11.1
16
8
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
11.1
863
7337
R60.0
ICD-10 Finland
Localized oedema
1.9
11.0
143
788
C82.1
ICD-10 Finland
Follicular lymphoma grade II
9.3
11.0
22
24
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
10.8
180
1072
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
10.7
66
270
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
10.6
116
602
WW400
NOMESCO Finland
Plasmaferesis
60.5
10.6
12
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
60.5
10.6
12
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.1
10.6
23
29
A28
ICPC
Limited function/disability NOS
1.7
10.6
191
1165
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
10.5
29
73
SPAT1254
SPAT
Administration of medicine
1.8
10.5
165
967
A05AA02
ATC
ursodeoxycholic acid; oral
4.1
10.4
28
69
R4190
NOMESCO Finland
Nutritional therapy
2.8
10.4
52
191
GDG10
NOMESCO Finland
Bilateral transplantation of lung
110.9
10.4
11
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.9
10.4
48
169
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
7.8
10.4
23
30
130
Kela drug reimbursment
Malignant tumour
2.0
10.4
116
608
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
32.8
10.3
13
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.2
10.3
21
41
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
18.9
10.3
15
8
C83.00
ICD-10 Finland
Lymphocytic lymphoma
18.9
10.3
15
8
L01XX52
ATC
venetoclax; oral
23.6
10.2
14
6
WX722
NOMESCO Finland
PEEP
2.6
10.2
59
234
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.4
10.2
68
289
P01AB01
ATC
metronidazole; oral, rectal
1.5
10.2
458
3471
R03DA04
ATC
theophylline; systemic, rectal
2.6
10.1
59
235
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.3
10.1
20
38
L01CA04
ATC
vinorelbine; systemic
8.0
10.1
22
28
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.5
10.1
65
272
N02AA01
ATC
morphine; systemic, rectal
4.0
10.1
28
71
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.4
10.0
35
104
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.0
10.0
45
156
ZY010
NOMESCO Finland
Hospital outpatient
2.4
10.0
66
279
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
10.0
61
249
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.2
9.9
39
125
L28
ICPC
Limited function/disability (L)
1.7
9.9
200
1257
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
16.8
9.9
15
9
V03AE02
ATC
sevelamer; oral
12.3
9.9
17
14
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.2
9.9
20
39
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.7
9.8
31
86
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
9.8
73
326
J04BA02
ATC
dapsone; oral
9.6
9.8
19
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.2
9.7
78
360
UDC00
NOMESCO Finland
Ear microscopy
2.1
9.7
95
475
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.3
9.6
35
107
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.6
9.5
22
48
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
9.2
9.5
19
21
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.1
9.5
18
18
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
9.5
236
1565
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
9.5
101
520
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.6
9.5
54
213
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
9.5
92
458
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.1
9.4
38
124
J17.2
ICD-10 Finland
Pneumonia in mycoses
+∞
9.4
9
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
9.4
9
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
4.9
9.3
20
41
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
9.3
58
239
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
9.3
38
125
S18
ICPC
Laceration/cut
1.4
9.2
546
4340
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
9.2
55
222
SPAT1301
SPAT
No procedures
1.5
9.2
367
2703
M31.3
ICD-10 Finland
Wegener granulomatosis
13.8
9.2
15
11
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.6
9.1
29
81
WX730
NOMESCO Finland
Conventional respirator
4.8
9.1
20
42
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
11.6
9.1
16
14
ZX121
NOMESCO Finland
Central venous catheter
15.7
9.0
14
9
L04AX05
ATC
pirfenidone; oral
15.7
9.0
14
9
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
7.1
9.0
21
30
L01EL01
ATC
ibrutinib; oral
37.0
9.0
11
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
37.0
9.0
11
*
ZXA00
NOMESCO Finland
Right side
1.5
9.0
312
2232
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.4
8.9
31
92
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
8.9
42
150
ED1AA
NOMESCO Finland
Mandibular X-ray examination
8.0
8.9
19
24
N06AA09
ATC
amitriptyline; systemic
1.9
8.8
109
591
A07EC02
ATC
mesalazine; oral, rectal
2.2
8.8
71
328
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.2
8.8
72
335
J96.9
ICD-10 Finland
Respiratory failure, unspecified
10.8
8.8
16
15
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
8.8
183
1160
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.2
8.7
23
56
WX872
NOMESCO Finland
Intensive care
2.3
8.7
63
278
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.5
8.7
52
210
A02BC05
ATC
esomeprazole; systemic
1.4
8.7
465
3617
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.6
8.7
28
79
J94.9
ICD-10 Finland
Pleural condition, unspecified
14.1
8.7
14
10
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
14.1
8.7
14
10
M10.9
ICD-10 Finland
Gout, unspecified
2.1
8.7
87
438
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
8.7
81
397
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
50.3
8.7
10
*
H05BX02
ATC
paricalcitol; systemic
50.3
8.7
10
*
A04AD12
ATC
aprepitant; systemic
3.4
8.7
31
94
XF600, ,
SPAT
2.9
8.6
39
136
A06AH03
ATC
naloxegol; oral
3.8
8.6
26
70
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.4
8.6
21
48
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.3
8.6
18
22
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.4
8.6
56
236
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
11.7
8.6
15
13
ZXA05
NOMESCO Finland
Left side
1.5
8.6
287
2034
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
8.6
69
319
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
16.4
8.6
13
8
A07EA06
ATC
budesonide; oral, local oral
2.6
8.6
49
194
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.6
8.5
28
80
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.5
95
497
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
9.0
8.5
17
19
329
Kela drug reimbursment
Lenalidomide
10.1
8.5
16
16
TGD00
NOMESCO Finland
Needle biopsy of lung
10.1
8.5
16
16
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
8.5
101
540
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
8.5
151
916
WX721
NOMESCO Finland
Oxygen concentrator therapy
27.7
8.5
11
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
27.7
8.5
11
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
8.5
112
621
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
20.2
8.5
12
6
ZX131
NOMESCO Finland
Intrathecal
90.6
8.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.5
8.4
28
81
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.8
8.4
14
11
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.9
8.4
18
37
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
4.0
8.4
23
58
B44.9
ICD-10 Finland
Aspergillosis, unspecified
+∞
8.3
8
*
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
8.3
8
*
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
8.3
8
*
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.4
8.3
56
240
C08CA01
ATC
amlodipine; oral
1.4
8.3
448
3486
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
7.1
8.3
19
27
B01AA03
ATC
warfarin; systemic
1.6
8.3
211
1406
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.3
8.2
21
50
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
6.5
8.2
20
31
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
8.2
83
420
SPAT1260
SPAT
Consultation of another employee
1.6
8.2
200
1318
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
7.6
8.2
18
24
N03AX14
ATC
levetiracetam; systemic
3.0
8.2
36
124
TAB00
NOMESCO Finland
Lumbar puncture
2.3
8.1
59
261
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
4.8
8.1
18
38
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
8.1
331
2441
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
4.1
8.1
22
55
284
Kela drug reimbursment
Nintedanib and pirfenidone
11.8
8.1
14
12
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
17.3
8.1
12
7
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
8.1
146
890
196
Kela drug reimbursment
Paricalcitol and cinacalcet
10.1
8.0
15
15
XQ855, ,
SPAT
6.3
8.0
20
32
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.9
8.0
23
60
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.5
8.0
49
201
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
7.9
119
687
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
7.9
61
277
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.7
7.9
24
65
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
7.9
149
918
XG466
NOMESCO Finland
Sleep oxymetry
2.9
7.9
35
121
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.1
7.9
13
10
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.6
7.9
25
70
R03AC03
ATC
terbutaline; inhalant
1.7
7.8
148
913
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
3.3
7.8
28
85
H05BX01
ATC
cinacalcet; oral
8.5
7.8
16
19
J01DA01
ATC
[U] cefalexin
1.4
7.8
724
6160
H26.3
ICD-10 Finland
Drug-induced cataract
9.5
7.8
15
16
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.7
7.8
24
66
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.2
7.7
20
48
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
15.1
7.7
12
8
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
45.2
7.7
9
*
3AC01, ,
NOMESCO Finland
6.0
7.7
20
34
Z2221
NOMESCO Finland
Medical doctor
1.5
7.7
306
2242
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
7.5
7.7
17
23
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.5
7.7
18
40
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.6
7.6
43
169
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
7.6
434
3397
WVA20
NOMESCO Finland
Medicine administration
2.9
7.6
34
118
R03AC13
ATC
formoterol; inhalant
2.3
7.6
57
256
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
7.6
100
554
L02BG06
ATC
exemestane; oral
3.6
7.6
24
67
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
25.2
7.6
10
*
N06AX11
ATC
mirtazapine; oral
1.4
7.6
368
2800
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.9
7.5
15
17
V03AE03
ATC
lanthanum carbonate; oral
10.1
7.5
14
14
C01BD01
ATC
amiodarone; systemic
2.9
7.5
34
119
WF002
NOMESCO Finland
Radical radiotherapy
2.1
7.5
73
364
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.1
7.5
30
98
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.4
7.4
18
41
J01FA15
ATC
telithromycin; oral
1.8
7.4
107
610
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
80.5
7.4
8
*
J02AC04
ATC
posaconazole; systemic
80.5
7.4
8
*
J45
ICD-10 Finland
Asthma
1.8
7.4
105
596
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.4
338
2541
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.4
7.4
51
221
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.0
7.4
83
437
205
Kela drug reimbursment
Chronic hypertension
1.5
7.4
314
2330
GX1K5
NOMESCO Finland
Diffusion capacity
8.4
7.3
15
18
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
+∞
7.3
7
*
47099
ICD-8 Finland
Influenza, unqualified
+∞
7.3
7
*
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
+∞
7.3
7
*
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
9.4
7.3
14
15
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
4.2
7.3
19
46
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.3
7.3
27
84
N06AB10
ATC
escitalopram; oral
1.5
7.3
210
1438
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
15.8
7.2
11
7
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.3
7.2
18
42
SAA04
NOMESCO Finland
Special examination of mouth
2.1
7.2
65
315
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
7.2
88
476
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
7.2
48
205
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.3
7.2
54
243
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.2
7.2
56
256
TQW80
NOMESCO Finland
Local dermatologic skincare
2.8
7.2
35
128
B73
ICPC
Leukaemia
30.2
7.2
9
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
30.2
7.2
9
*
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.9
7.1
33
117
A12AA12
ATC
[U] calcium acetate
20.1
7.1
10
5
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
20.1
7.1
10
5
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
8.0
7.1
15
19
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.2
7.1
59
277
356
Kela drug reimbursment
Nintedanib and pirfenidone
12.1
7.1
12
10
N06AB04
ATC
citalopram; systemic
1.5
7.0
222
1548
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.9
7.0
31
107
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
10.1
7.0
13
13
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
7.0
126
766
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
3.5
7.0
23
66
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.5
7.0
43
177
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
7.0
337
2557
E86
ICD-10 Finland
Volume depletion
3.0
6.9
29
97
B05DB
ATC
Hypertonic solutions
6.4
6.9
17
27
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.4
6.9
17
27
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.9
474
3814
SPAT1325
SPAT
Vaccination
1.4
6.9
389
3029
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.9
201
1377
UJF92
NOMESCO Finland
Capsular endoscopy
3.1
6.9
27
87
ZX080
NOMESCO Finland
Image guided radiotherapy
2.9
6.9
32
114
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
6.9
76
398
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.4
6.8
24
72
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.4
6.8
24
72
A10AE04
ATC
insulin glargine; parenteral
1.8
6.8
109
641
R03BB01
ATC
ipratropium bromide; inhalant
2.5
6.8
40
161
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
11.0
6.8
12
11
TPX15
NOMESCO Finland
Removal of vascular injection port
11.0
6.8
12
11
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.0
6.8
72
371
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
6.8
97
552
1CD02, ,
NOMESCO Finland
5.7
6.8
18
32
WW402
NOMESCO Finland
Leucoferesis
40.3
6.8
8
*
XX4BW, ,
NOMESCO Finland
40.3
6.8
8
*
J01FA01
ATC
erythromycin; systemic
1.7
6.7
138
870
R96
ICPC
Asthma
1.8
6.7
97
554
B74
ICPC
Malignant neoplasm blood other
22.6
6.7
9
*
5AB14, ,
NOMESCO Finland
22.6
6.7
9
*
B01AB04
ATC
dalteparin; parenteral
2.1
6.6
58
278
WX610
NOMESCO Finland
Patient controlled analgesia
6.5
6.6
16
25
ZX120, ,
SPAT
5.5
6.6
18
33
J01DA09
ATC
[U] cefadroxil
1.4
6.6
292
2176
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
6.6
189
1290
R2110
NOMESCO Finland
Giving the first information
2.0
6.6
70
361
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
12.3
6.6
11
9
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
6.6
85
469
R05
ICPC
Cough
1.5
6.6
252
1828
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.1
6.5
12
12
M81.4
ICD-10 Finland
Drug-induced osteoporosis
10.1
6.5
12
12
WPB10
NOMESCO Finland
Making a convalescent care decision
10.1
6.5
12
12
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
6.9
6.5
15
22
R06.2
ICD-10 Finland
Wheezing
2.3
6.5
49
221
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.6
6.5
35
135
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
6.5
57
274
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.7
6.5
20
55
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
6.5
288
2149
N05CD07
ATC
temazepam; oral
1.7
6.4
127
793
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
7.4
6.4
14
19
R03BC03
ATC
nedocromil; inhalant
1.9
6.4
77
415
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
14.4
6.4
10
7
N06AX21
ATC
duloxetine; oral
1.7
6.4
128
802
J45.8
ICD-10 Finland
Mixed asthma
2.7
6.4
32
119
A02BC03
ATC
lansoprazole; oral
1.4
6.4
319
2430
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
18.1
6.3
9
5
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
18.1
6.3
9
5
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
6.3
91
521
J17.3*B58.3
ICD-10 Finland
Pulmonary toxoplasmosis
+∞
6.3
6
*
4809X
ICD-9 Finland
Viral pneumonia, unspecified
+∞
6.3
6
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
6.3
6
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
6.3
6
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
6.3
6
*
5AH02, ,
NOMESCO Finland
+∞
6.3
6
*
1XX08, ,
NOMESCO Finland
+∞
6.3
6
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
6.3
6
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
6.3
6
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
6.3
6
*
R51.80
ICD-10 Finland
Headache
1.6
6.3
162
1081
A10BH05
ATC
linagliptin; oral
2.1
6.2
58
285
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
26.8
6.2
8
*
1AA09, ,
NOMESCO Finland
26.8
6.2
8
*
B01AC04
ATC
clopidogrel; oral
1.5
6.2
191
1323
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
7.1
6.2
14
20
OAB50, ,
SPAT
2.0
6.2
68
355
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
6.2
96
560
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.2
198
1383
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.1
6.2
18
36
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.0
6.2
17
43
R50.8
ICD-10 Finland
Other specified fever
7.7
6.1
13
17
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
12.6
6.1
10
8
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.6
6.1
33
128
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.1
124
1894
GDC00
NOMESCO Finland
Lobectomy of lung
8.6
6.1
12
14
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
6.7
6.0
14
21
J01DC02
ATC
cefuroxime; systemic
2.1
6.0
58
289
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
5.2
6.0
17
33
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.8
6.0
83
468
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
6.0
296
2246

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
753
2251
6.48
255.30
10.2
3.5
—
—
—
0
0
172
72
27.33
245.83
3.0
2.2
1.01
1.17
e9/l
1.14
167
63
274
287
11.79
242.84
3.0
1.7
0.71
2.42
ug/l
0.95
254
244
383
677
7.57
220.58
5.7
2.5
8.36
10.87
g/l
15.50
371
615
164
85
21.90
214.64
3.2
2.1
—
—
—
0
0
125
49
28.08
182.09
3.6
3.1
35.32
42.45
%
1.08
81
28
494
1342
5.29
176.37
2.5
1.9
—
—
—
0
0
152
110
15.49
168.05
3.0
2.3
—
—
—
0
0
442
1136
5.35
167.55
2.2
1.3
—
—
—
0
0
347
765
5.80
155.67
9.1
3.8
1.25
0.83
%
2.12
253
254
285
534
6.54
151.55
2.6
1.7
1.08
1.44
g/l
2.04
259
492
90
25
38.57
145.41
2.1
2.1
—
—
—
0
0
84
21
42.66
139.36
1.4
1.0
—
—
—
0
0
468
1523
4.22
127.08
6.9
2.9
0.80
0.82
mmol/l
2.42
448
1431
212
352
6.99
125.93
2.6
1.5
9.18
10.12
u/ml
—
13
10
98
54
19.53
123.81
3.3
2.0
504.65
429.26
e6/l
0.68
89
43
292
694
5.12
117.99
8.9
3.6
0.64
0.55
%
0.41
202
213
404
1246
4.24
116.96
12.8
5.1
1.07
1.03
mmol/l
1.64
386
1148
882
4577
3.81
116.13
18.8
5.6
8.64
8.73
%
0.29
857
4266
883
4592
3.80
115.73
20.6
5.6
—
—
—
0
0
296
731
4.93
113.97
9.6
3.9
0.16
0.11
%
0.77
203
219
912
4878
3.83
113.64
15.9
5.2
0.04
0.04
e9/l
1.07
843
4197
910
4862
3.83
113.54
16.0
5.2
0.68
0.58
e9/l
1.74
841
4187
874
4559
3.73
113.00
17.7
5.3
2.35
2.95
%
14.49
848
4241
136
152
9.86
112.69
2.3
1.6
—
—
—
0
0
854
4421
3.65
111.04
17.3
5.4
0.61
0.70
%
3.98
831
4102
887
4705
3.72
110.92
17.9
5.4
25.25
28.41
%
9.29
862
4397
79
34
24.66
110.54
1.4
1.3
—
—
—
0
0
877
4642
3.67
109.52
16.4
5.2
59.59
56.58
%
7.78
854
4331
919
5017
3.76
109.14
16.3
5.2
2.20
1.97
e9/l
0.49
860
4426
921
5038
3.76
108.97
17.6
5.4
0.17
0.19
e9/l
5.04
865
4411
336
994
4.20
101.61
9.7
7.2
4.86
5.09
kpa
4.15
320
957
273
690
4.73
101.42
9.6
4.0
0.48
0.54
%
0.04
181
178
335
994
4.18
100.83
9.7
7.2
10.86
13.10
kpa
12.86
318
957
332
991
4.14
98.95
9.7
7.3
1.34
0.75
mmol/l
2.25
270
773
136
184
8.13
96.49
6.2
3.5
—
—
—
0
0
237
555
4.99
96.39
6.4
5.4
—
—
—
0
0
437
1607
3.57
95.48
1.9
1.8
—
—
—
0
0
908
5168
3.44
95.41
16.0
5.7
10.66
11.87
umol/l
1.88
885
4887
127
168
8.26
91.75
3.5
2.3
15.43
16.34
%
1.08
77
89
102
102
10.76
91.31
1.7
1.3
—
—
—
0
0
338
1084
3.85
90.25
6.0
2.4
2.02
1.75
%
3.13
314
957
52
11
49.18
89.16
2.5
1.4
—
—
—
0
0
281
799
4.20
88.79
5.7
2.4
72.05
68.87
e9/l
0.60
221
624
128
180
7.77
87.69
1.5
1.4
—
—
—
0
0
950
5739
3.36
86.51
30.2
7.9
4.44
3.97
e9/l
7.12
895
4982
121
162
8.12
86.45
1.5
1.4
97.29
138.83
u/ml
0.83
20
30
280
825
4.04
83.91
9.1
3.0
1.87
1.47
mmol/l
1.05
239
666
288
869
3.96
83.43
8.9
3.0
7.39
7.39
ph
—
6
7
291
897
3.88
81.63
10.0
7.7
94.15
96.23
%
4.16
279
867
847
4946
3.00
78.74
18.1
5.8
1.20
1.21
mmol/l
4.66
715
4188
770
4281
2.92
78.31
11.0
4.5
33.34
35.97
g/l
25.99
732
3986
594
2888
2.93
77.58
11.3
3.5
7.40
7.40
ph
1.15
167
543
275
843
3.86
77.48
2.6
2.2
360.86
365.19
nmol/l
0.09
264
780
114
162
7.61
77.23
1.4
1.2
260.75
244.02
u/ml
0.22
80
93
237
660
4.16
76.35
1.6
1.4
—
—
—
0
0
104
135
8.28
76.11
7.7
3.3
1.38
1.15
%
0.38
98
124
80
73
11.60
76.04
1.4
1.3
2.05
2.82
g/l
1.80
50
47
80
73
11.60
76.04
1.4
1.3
0.42
0.39
g/l
0.20
48
45
79
73
11.45
74.45
1.4
1.3
6.88
6.96
g/l
0.03
48
46
101
131
8.27
73.94
2.2
1.3
—
—
—
0
0
811
4741
2.85
73.13
16.2
13.8
1.20
1.25
inr
1.25
290
1369
213
565
4.30
73.09
5.2
2.9
7.43
7.41
ph
2.17
49
64
214
570
4.29
73.03
5.2
2.9
4.97
5.05
kpa
0.70
203
541
98
126
8.32
72.25
1.4
1.6
0.48
0.92
g/l
2.21
61
98
78
74
11.14
72.20
1.4
1.4
—
—
—
0
0
348
1307
3.26
70.95
4.0
2.4
22.42
23.58
%
0.74
301
1128
178
420
4.74
70.84
2.5
1.8
1.55
1.49
g/l
0.28
149
361
777
4502
2.77
70.26
15.6
5.2
1.20
1.21
mmol/l
3.74
737
4061
379
1518
3.10
69.02
3.9
2.3
11.69
13.50
umol/l
5.45
365
1413
104
152
7.34
68.59
4.3
2.6
—
—
—
0
0
356
1396
3.12
67.04
3.9
2.3
2.15
2.34
g/l
7.32
337
1290
138
277
5.45
66.22
1.4
1.2
—
—
—
0
0
259
844
3.58
65.89
11.3
8.1
115.60
121.72
g/l
4.04
251
823
46
19
25.05
64.98
1.6
1.2
—
—
—
0
0
289
1026
3.33
64.07
2.0
1.6
—
—
—
0
0
577
2992
2.65
63.40
5.4
3.1
49.43
60.98
e6/l
0.20
503
2299
455
2095
2.79
63.35
4.1
2.4
4.76
4.79
e6/l
0.02
435
1881
237
753
3.62
62.47
5.3
2.3
62.80
66.88
g/l
8.69
230
673
245
797
3.55
62.27
17.8
6.6
11.68
9.60
mmol/l
4.01
239
753
435
1984
2.78
61.37
4.6
2.7
521.14
553.84
mosm/kgh2o
2.83
410
1697
579
3076
2.58
59.62
3.6
2.4
60.87
85.46
u/l
0.45
546
2824
442
2070
2.71
58.80
2.4
1.6
1.64
1.19
mg/l
0.96
376
1535
106
187
6.08
58.23
3.3
2.3
122.78
131.28
g/l
2.10
83
147
330
1332
2.97
58.16
1.9
1.6
—
—
—
0
0
355
1505
2.86
57.02
3.7
1.8
29.92
29.49
s
0.58
349
1459
530
2753
2.55
56.56
5.3
3.0
0.28
0.33
e6/l
0.36
454
2094
165
436
4.18
56.36
9.6
9.3
24.39
23.87
mmol/l
1.45
160
424
225
738
3.47
56.12
12.7
7.4
—
—
—
0
0
901
6009
2.58
55.25
11.0
4.1
6.74
6.68
mmol/l
0.35
866
5588
622
3517
2.46
54.76
6.3
3.4
50.00
109.39
e6/l
1.44
519
2492
74
97
8.02
53.52
5.9
6.4
11.51
11.49
mg/l
0.01
67
89
103
192
5.74
53.37
2.1
1.8
—
—
—
0
0
204
649
3.54
53.22
4.9
2.1
—
—
—
0
0
409
1922
2.64
53.21
2.4
1.4
2.24
2.45
g/l
1.05
322
1150
116
245
5.10
52.31
6.0
3.3
1.87
1.53
mg/l
3.00
110
219
509
2676
2.47
51.99
7.0
2.5
2607.25
7655.37
umol/l
2.42
474
2316
306
1259
2.86
51.43
1.7
1.3
371.65
520.94
titre
1.02
79
254
528
2836
2.44
51.28
4.6
2.6
1963.42
1159.18
ng/l
2.96
468
2397
240
871
3.15
50.41
1.7
1.4
—
—
—
0
0
73
101
7.59
50.38
1.2
1.3
—
—
—
0
0
184
567
3.61
50.27
11.7
7.5
24.53
24.40
mmol/l
0.17
175
542
97
182
5.67
49.87
8.4
4.1
2.54
2.59
mmol/l
0.05
74
110
279
1119
2.90
48.96
2.1
1.6
—
—
—
0
0
151
415
3.98
48.66
9.7
3.1
23.90
23.69
mmol/l
0.37
151
408
501
2681
2.40
48.49
5.2
2.9
—
—
—
0
0
73
107
7.16
47.84
2.4
2.6
—
—
—
0
0
119
279
4.59
47.26
7.0
2.8
61.65
49.72
mg/l
0.53
90
228
117
272
4.62
46.95
6.9
2.7
20.23
1.54
ratio
—
7
29
103
216
5.09
46.76
8.7
3.8
7.43
7.42
ph
2.35
97
201
37
20
19.01
46.65
3.1
1.9
110.00
203.33
e6/l
—
22
6
118
279
4.55
46.36
7.1
2.8
57.70
76.92
mg/l
0.18
88
229
521
2888
2.33
45.97
3.9
2.9
—
—
—
0
0
219
808
3.05
44.37
9.3
3.5
1.22
1.22
mmol/l
0.44
205
685
91
180
5.36
44.11
6.6
3.4
59.70
57.21
%
0.73
91
180
98
208
5.01
43.84
7.1
3.0
—
—
—
0
0
135
370
3.95
43.56
9.1
5.1
1.81
1.60
%
0.95
127
349
457
2448
2.33
43.13
22.0
6.0
—
—
—
0
0
574
3400
2.22
42.29
7.4
3.1
2.33
2.35
mmol/l
4.88
528
2967
64
93
7.18
42.24
1.5
1.1
—
—
—
0
0
64
93
7.18
42.24
1.2
1.1
—
—
—
0
0
169
557
3.33
41.26
2.1
1.2
321.86
208.60
u/ml
0.44
157
514
925
6678
2.30
40.85
6.7
4.1
944.84
2679.94
e6/l
0.66
17
95
130
364
3.85
40.63
9.5
5.2
0.90
0.88
%
0.11
122
344
698
4540
2.14
39.73
28.9
8.4
0.01
0.00
e9/l
0.65
619
3738
1042
7963
2.48
39.57
22.2
6.7
82.62
77.46
u/l
2.97
1018
7432
39
32
12.53
39.41
1.3
1.1
—
—
—
0
0
456
2517
2.24
39.38
2.8
2.0
3.30
2.93
mg/l
2.66
413
2128
545
3232
2.17
39.30
6.2
3.0
36.95
33.33
u/l
0.63
526
3064
106
266
4.25
38.47
2.0
1.5
0.24
0.24
g/l
0.01
99
253
955
7093
2.26
37.73
7.2
3.9
—
—
—
0
0
156
524
3.24
36.79
1.5
1.2
—
—
—
0
0
107
280
4.07
36.69
2.0
1.4
1.17
1.18
g/l
0.17
102
264
142
463
3.32
35.11
15.8
9.9
—
—
—
0
0
998
7655
2.26
34.76
9.0
3.7
18.43
10.93
mm/h
28.56
960
7020
606
3875
2.05
34.53
5.6
3.2
120.37
64.24
ng/l
0.28
478
2651
56
90
6.45
33.61
11.8
3.4
—
—
—
0
0
352
1855
2.23
33.16
5.6
3.4
158.65
427.71
ng/l
2.88
292
1440
194
783
2.73
32.79
3.9
2.6
168.63
173.54
ng/l
0.07
180
710
116
348
3.56
32.63
1.4
1.3
0.20
0.51
u/ml
—
5
34
45
60
7.73
31.97
2.3
1.1
5.73
1.16
u/ml
0.67
27
29
717
4973
1.97
31.37
5.6
3.4
0.00
0.00
estimate
0.50
197
1006
80
189
4.44
31.33
1.5
1.1
—
—
—
0
0
721
5033
1.96
30.70
5.6
3.4
0.00
0.01
estimate
0.80
184
904
714
4969
1.96
30.67
7.4
4.5
0.00
0.00
estimate
0.50
192
951
232
1066
2.43
29.81
5.7
2.6
8.91
8.92
umol/l
0.00
208
934
206
910
2.50
28.77
2.8
2.3
0.22
0.21
g/l
0.18
191
856
695
4870
1.91
28.43
5.1
2.4
—
—
—
0
0
90
253
3.75
27.83
1.9
2.1
11.22
11.25
mg/l
0.01
83
229
63
136
4.81
27.55
5.3
2.0
—
—
—
0
0
49
85
5.95
27.25
9.0
2.9
56.37
52.70
%
0.49
44
71
35
11
32.64
26.93
1.3
1.2
—
—
—
0
0
115
387
3.16
26.85
6.6
4.6
—
—
—
0
0
502
3219
1.90
26.46
5.1
2.2
—
—
—
0
0
607
4145
1.86
26.20
3.2
2.2
76.59
77.39
nmol/l
0.29
570
3666
308
1674
2.10
26.03
4.3
2.6
1.10
1.10
e6/l
0.00
202
970
168
706
2.58
25.93
6.2
3.6
104.01
82.25
ng/l
2.29
150
616
92
279
3.47
25.39
10.1
6.4
1.37
1.29
mmol/l
0.37
85
244
624
4334
1.84
25.18
4.5
2.6
302.63
129.09
ug/l
4.56
592
3974
581
3957
1.84
24.91
5.0
3.1
5.79
5.81
ph
0.04
26
287
289
1561
2.09
24.69
4.7
2.8
1.84
1.87
e6/l
0.03
184
864
49
94
5.38
24.50
1.4
1.2
—
—
—
0
0
29
33
8.96
23.36
1.1
1.2
—
—
—
0
0
88
274
3.37
23.29
4.0
3.2
—
—
—
0
0
62
152
4.23
23.14
1.1
1.1
—
—
—
0
0
100
339
3.11
23.02
5.6
4.2
1.49
1.35
mmol/l
0.63
95
334
112
420
2.82
21.53
5.9
2.8
—
—
—
0
0
319
1880
1.92
20.90
4.2
2.8
2.45
2.44
mmol/l
0.74
288
1646
34
54
6.44
20.61
2.5
1.9
—
—
—
0
0
58
148
4.05
20.53
1.2
1.1
—
—
—
0
0
28
36
7.93
20.46
2.4
2.7
66.83
57.36
mg/l
0.23
23
28
29
40
7.39
19.98
1.9
2.5
7.44
7.44
ph
0.12
16
11
39
74
5.40
19.74
1.6
1.3
2614.50
1363.39
e6/l
0.91
32
56
179
873
2.22
19.56
3.8
2.1
36.36
96.90
u/l
0.58
160
758
395
2540
1.79
19.37
8.7
3.4
87.90
89.80
%
0.78
384
2477
36
66
5.58
18.91
1.4
1.1
209.00
93.85
titre
—
10
13
56
148
3.91
18.90
1.5
1.3
68.84
59.25
mmol/l
0.86
49
122
89
318
2.93
18.68
3.3
2.1
203.88
401.24
ug/l
0.76
82
301
51
128
4.10
18.47
5.5
2.2
32.61
32.59
pg
0.01
51
128
35
64
5.59
18.43
1.7
1.3
40896.52
167480.73
e6/l
0.71
25
40
65
194
3.47
18.38
11.2
7.8
11.45
11.16
mmol/l
0.25
60
176
65
194
3.47
18.38
11.2
7.8
104.32
105.73
mmol/l
1.75
60
176
174
863
2.17
18.18
2.4
2.2
7.06
7.72
ug/l
0.20
154
762
174
863
2.17
18.18
5.9
3.4
—
—
—
0
0
384
2488
1.77
18.15
4.4
2.2
—
—
—
0
0
25
33
7.70
17.86
1.9
1.7
—
—
—
0
0
308
1879
1.83
17.76
1.8
1.7
1225.14
1171.63
nmol/l
0.39
240
1396
449
3058
1.71
17.67
3.0
2.0
129.67
220.13
u/l
2.76
423
2856
32
56
5.83
17.63
1.6
1.3
—
—
—
0
0
197
1038
2.06
17.54
4.4
4.0
14.00
21.17
ug/l
0.25
157
856
27
40
6.87
17.45
1.8
1.8
—
—
—
0
0
28
19
15.03
17.17
1.1
1.1
—
—
—
0
0
49
128
3.94
16.82
1.2
1.2
—
—
—
0
0
566
4145
1.64
16.60
2.3
2.1
—
—
—
0
0
375
2480
1.72
16.18
1.9
1.5
18.54
21.06
nmol/l
2.55
334
2096
403
2719
1.69
16.14
5.8
3.7
0.00
0.01
estimate
0.88
167
916
404
2732
1.69
16.02
5.3
3.1
—
—
—
0
0
34
70
4.96
15.73
1.9
1.4
—
—
—
0
0
56
169
3.42
15.59
1.4
1.2
100.95
24.59
u/l
2.28
50
147
59
186
3.27
15.33
2.9
3.3
30.94
37.07
umol/l
1.32
53
168
39
96
4.16
14.52
1.1
1.1
—
—
—
0
0
1167
10488
2.00
14.23
48.2
11.4
27.71
22.19
mg/l
7.93
1076
8076
89
368
2.52
14.08
6.5
2.9
24.69
24.75
mmol/l
0.08
82
338
343
2287
1.68
14.05
5.0
3.4
—
—
—
0
0
25
22
11.56
13.81
1.0
1.0
—
—
—
0
0
22
34
6.56
13.67
3.0
3.2
—
—
—
0
0
24
20
12.20
13.61
1.3
1.1
—
—
—
0
0
39
101
3.95
13.57
1.3
1.5
277.68
280.48
mosm/kgh2o
0.24
34
75
825
6800
1.57
13.54
4.9
3.0
66.98
48.10
u/l
5.09
790
6326
27
52
5.28
13.47
1.5
1.2
—
—
—
0
0
52
167
3.20
13.14
1.2
1.2
—
—
—
0
0
61
216
2.91
13.04
1.7
1.5
48.36
13.77
e6/l
0.57
50
175
50
161
3.19
12.59
6.6
3.3
—
—
—
0
0
37
98
3.86
12.50
4.9
1.5
—
—
—
0
0
66
254
2.68
12.09
1.7
1.2
7.57
2.42
u/ml
—
6
20
24
46
5.30
12.04
5.2
3.4
—
—
—
0
0
66
258
2.64
11.73
1.7
1.2
5.50
7.87
u/ml
—
10
36
29
67
4.40
11.73
2.2
1.6
—
—
—
0
0
21
19
11.21
11.55
4.2
4.7
—
—
—
0
0
96
449
2.23
11.53
1.4
1.2
—
—
—
0
0
554
4291
1.50
11.36
2.3
2.0
90.80
94.67
pmol/l
1.18
340
2206
18
12
15.18
11.32
1.8
1.0
—
—
—
0
0
18
12
15.18
11.32
1.8
1.0
—
—
—
0
0
18
12
15.18
11.32
1.8
1.0
—
—
—
0
0
16
8
20.22
11.14
1.4
1.0
—
—
—
0
0
36
103
3.57
10.92
1.2
1.2
—
—
—
0
0
19
16
12.03
10.85
1.1
1.1
—
—
—
0
0
19
16
12.03
10.85
1.1
1.1
—
—
—
0
0
19
16
12.03
10.85
1.1
1.1
—
—
—
0
0
23
28
8.34
10.82
1.6
1.3
—
—
—
0
0
19
18
10.69
10.29
1.8
1.1
—
—
—
0
0
24
53
4.59
10.26
1.0
1.0
—
—
—
0
0
254
1685
1.63
10.26
1.4
1.3
57.26
32.61
iu/ml
1.40
94
523
221
1415
1.68
10.25
1.3
1.2
—
—
—
0
0
396
2908
1.52
10.25
1.6
1.4
—
—
—
0
0
52
193
2.76
10.24
10.9
2.5
—
—
—
0
0
247
1628
1.64
10.23
1.3
1.3
24.85
12.28
u/ml
1.00
81
621
24
54
4.51
10.04
1.0
1.1
—
—
—
0
0
416
3109
1.49
9.82
5.3
3.6
—
—
—
0
0
56
222
2.59
9.72
7.8
2.6
1.51
1.53
mmol/l
0.08
56
217
37
117
3.22
9.64
1.5
1.3
—
57.10
—
0
7
16
14
11.55
9.07
1.7
1.2
—
—
—
0
0
117
648
1.88
8.89
4.4
3.0
4.32
5.24
e9/l
0.65
99
520
50
198
2.59
8.72
1.7
1.2
37.68
52.76
u/ml
—
10
17
45
170
2.71
8.61
1.4
1.6
—
—
—
0
0
49
194
2.58
8.55
1.7
1.5
—
—
—
0
0
43
160
2.74
8.47
8.2
3.0
53.06
28.35
u/ml
0.62
43
154
154
941
1.72
8.44
2.2
1.4
—
—
—
0
0
29
86
3.43
8.38
1.6
1.4
35.39
28.22
%
0.38
18
58
63
283
2.29
8.38
1.3
1.1
—
—
—
0
0
307
2217
1.50
8.36
1.6
1.7
72973429.72
41351332.10
pmol/l
0.25
259
1821
12
7
17.29
8.08
2.6
3.1
—
—
—
0
0
117
669
1.82
8.04
1.8
1.4
—
—
—
0
0
1012
9115
1.48
8.00
51.1
14.4
15.59
15.01
%
2.79
1007
8940
40
148
2.76
7.98
1.5
1.1
—
—
—
0
0
40
148
2.76
7.98
1.5
1.1
—
—
—
0
0
94
502
1.94
7.98
5.5
3.4
—
—
—
0
0
35
121
2.94
7.89
1.5
1.5
—
—
—
0
0
133
800
1.74
7.70
1.5
1.7
—
—
—
0
0
19
44
4.37
7.69
1.9
1.5
—
—
—
0
0
100
553
1.87
7.65
3.2
3.5
4.09
4.58
pmol/l
5.24
87
487
179
1170
1.61
7.56
1.3
1.3
—
—
—
0
0
1170
10913
1.65
7.49
46.3
13.9
138.83
139.74
mmol/l
26.07
1155
10606
140
862
1.70
7.45
4.8
3.3
—
—
—
0
0
59
272
2.22
7.41
1.3
1.2
—
1846.25
—
0
8
847
7431
1.39
7.40
5.7
3.7
—
—
—
0
0
12
9
13.44
7.39
1.0
1.0
—
—
—
0
0
1172
10948
1.64
7.32
46.9
14.0
3.99
3.98
mmol/l
1.11
1154
10625
32
110
2.96
7.31
5.0
2.5
0.87
1.77
g/24h
0.76
22
55
299
2206
1.46
7.20
5.9
3.6
1.01
1.02
kg/l
1.07
39
301
32
111
2.93
7.20
1.8
1.6
57.95
62.68
%
0.23
19
71
56
260
2.21
6.93
1.3
1.2
96.00
60.53
titre
—
10
19
15
20
7.57
6.90
1.4
1.4
—
—
—
0
0
51
229
2.28
6.84
2.0
1.7
10677.80
15084.31
e6/l
0.54
41
166
19
49
3.92
6.72
1.6
1.5
—
—
—
0
0
26
84
3.14
6.61
1.9
2.1
585.38
637.61
ml
0.30
21
56
22
64
3.48
6.58
1.6
1.9
517.06
497.06
min
0.42
17
47
26
85
3.10
6.49
5.0
3.0
—
—
—
0
0
22
65
3.43
6.43
1.2
1.1
—
—
—
0
0
16
27
5.99
6.31
1.7
1.7
—
—
—
0
0
11
10
11.08
6.30
1.8
2.0
22.83
6.60
%
—
6
5
52
246
2.16
6.17
1.2
1.3
183.31
230.31
miu/ml
0.37
15
116
39
163
2.44
6.16
1.3
1.1
3.07
4.75
u/ml
0.51
15
65
174
1185
1.54
6.13
3.3
2.3
199.49
132.86
ug/g
1.19
147
938
21
64
3.32
5.87
1.5
1.2
—
—
—
0
0
17
45
3.81
5.82
1.6
1.4
0.92
1.12
nmol/l
0.38
12
34
19
55
3.49
5.74
1.2
1.7
6.49
6.30
u/l
0.04
14
45
72
394
1.88
5.74
3.7
3.1
408.60
9926.17
u/ml
0.77
65
342
32
126
2.58
5.73
5.4
2.2
4.27
4.05
mmol/l
1.26
32
126
52
255
2.08
5.66
1.5
1.5
9.76
9.40
u/l
0.05
38
210
28
104
2.73
5.62
1.5
1.6
—
—
—
0
0
17
36
4.77
5.62
1.1
1.1
—
—
—
0
0
9
7
12.93
5.58
1.4
1.0
—
—
—
0
0
77
436
1.81
5.52
2.6
1.8
—
—
—
0
0
31
123
2.56
5.48
5.5
2.2
—
—
—
0
0
90
536
1.73
5.44
2.4
2.3
—
—
—
0
0
14
25
5.65
5.38
1.2
1.2
—
—
—
0
0
31
126
2.50
5.23
5.5
2.2
105.39
105.66
mmol/l
0.11
31
126
8
6
13.40
5.08
3.6
3.5
—
—
—
0
0
51
261
1.99
4.98
6.3
4.2
—
—
—
0
0
34
149
2.32
4.89
1.4
1.4
—
—
—
0
0
25
95
2.66
4.83
1.5
1.3
9628.18
117950.32
e6/l
0.87
17
66
14
29
4.87
4.81
2.8
1.9
—
—
—
0
0
9
10
9.05
4.78
13.4
9.5
5.04
6.73
mmol/l
—
9
10
1188
11319
1.51
4.69
27.1
9.5
28.02
26.61
u/l
0.92
1167
10881
14
30
4.71
4.68
1.0
1.1
—
—
—
0
0
49
258
1.93
4.44
3.6
2.5
—
—
—
0
0
37
178
2.11
4.29
2.2
3.1
0.88
0.82
nmol/l
0.23
28
135
29
126
2.33
4.29
1.5
1.2
—
—
—
0
0
7
6
11.72
4.28
1.3
1.0
—
—
—
0
0
48
255
1.92
4.25
2.1
2.2
148.18
122.74
ug/min
0.18
32
156
7
7
10.04
4.01
1.3
1.1
—
—
—
0
0
11
22
5.03
4.00
1.1
1.2
—
—
—
0
0
179
1332
1.40
4.00
1.3
1.3
—
—
—
0
0
17
59
2.91
3.90
1.4
1.5
—
—
—
0
0
864
7930
1.26
3.83
4.7
3.8
14.82
14.79
pmol/l
0.13
799
7165
51
288
1.80
3.77
1.4
1.5
252.04
286.85
ug/g
0.50
28
174
104
707
1.51
3.74
2.2
2.5
19.76
22.38
au/ml
—
5
54
20
78
2.59
3.72
2.4
1.9
0.83
2.23
u/field
1.04
12
31
1156
11046
1.38
3.62
34.8
11.8
—
—
—
0
0
12
30
4.03
3.60
1.0
1.0
—
—
—
0
0
20
80
2.52
3.55
5.7
3.1
38.90
22.02
u/ml
0.78
20
80
14
46
3.07
3.53
1.6
1.3
—
—
—
0
0
6
6
10.04
3.50
1.3
1.0
—
—
—
0
0
6
6
10.04
3.50
1.3
1.0
—
—
—
0
0
96
653
1.51
3.46
3.4
2.7
—
—
—
0
0
48
276
1.77
3.38
3.5
2.2
5345.58
2411.47
u/l
0.46
21
114
393
3341
1.25
3.34
5.2
3.7
11.32
7.24
mg/mmol
1.73
284
2095
271
2205
1.29
3.31
1.3
1.2
0.89
1.53
u/ml
1.25
73
582
11
28
3.95
3.29
1.2
1.3
—
—
—
0
0
375
3177
1.25
3.28
5.0
3.2
1242.59
229.05
mg/l
1.96
280
2008
9
19
4.76
3.24
2.6
2.0
—
—
—
0
0
12
34
3.55
3.20
6.1
1.7
—
—
—
0
0
12
34
3.55
3.20
2.3
5.2
111.17
116.10
umol/l
—
6
21
7
11
6.39
3.18
1.3
1.2
178.14
122.91
ng/l
—
7
11
19
79
2.43
3.14
17.8
1.7
8.99
10.99
%
1.68
19
79
393
3363
1.24
3.12
4.9
3.1
7.29
7.80
mmol/l
1.39
346
2820
24
112
2.16
3.07
1.1
1.1
—
—
—
0
0
59
370
1.62
3.05
3.8
3.2
0.35
0.24
g/l
0.38
41
145
6
9
6.69
2.87
1.0
1.0
—
—
—
0
0
17
71
2.41
2.80
1.5
1.4
—
—
—
0
0
8
18
4.46
2.79
2.4
2.2
1.15
1.16
mmol/l
—
8
18
7
14
5.02
2.73
1.0
1.9
15.31
16.39
umol/l
—
7
14
203
2494
0.78
2.71
2.5
3.1
0.74
0.76
ug/l
0.14
131
1634
14
54
2.61
2.70
1.2
1.1
1.10
1.08
ratio
—
8
18
38
619
0.60
2.50
1.8
1.4
—
—
—
0
0
1036
10797
0.81
2.48
5.3
4.9
2.65
2.74
mmol/l
2.86
938
9911
13
51
2.56
2.44
2.2
1.2
137.38
133.04
nmol/l
0.12
13
51
5
8
6.27
2.37
5.6
3.3
22.14
43.20
g/mol
—
5
8
8
22
3.65
2.36
5.5
3.0
—
—
—
0
0
6
13
4.63
2.27
1.7
1.8
—
—
—
0
0
9
29
3.12
2.22
1.0
1.2
—
—
—
0
0
1012
9672
1.20
2.09
5.4
4.5
2.09
2.07
mu/l
0.05
930
8796
29
168
1.74
2.09
1.7
1.4
—
—
—
0
0
7
20
3.51
2.05
6.6
3.1
—
—
—
0
0
54
368
1.49
2.03
1.6
1.4
26.53
28.41
iu/l
0.13
42
315
19
97
1.97
2.00
1.5
1.2
1.32
1.52
nmol/l
0.40
19
87
6
16
3.76
1.93
1.3
1.4
—
—
—
0
0
22
121
1.83
1.89
1.5
1.4
32.71
25.09
u/l
0.41
16
97
6
17
3.54
1.84
5.7
7.6
—
—
—
0
0
5
12
4.18
1.82
1.0
1.1
0.02
0.58
u/ml
—
5
12
23
130
1.78
1.82
8.1
2.5
—
—
—
0
0
86
652
1.34
1.81
1.2
1.2
120.08
152.42
iu/ml
0.40
32
265
9
35
2.58
1.80
2.6
2.4
—
—
—
0
0
7
24
2.93
1.72
6.6
8.3
—
—
—
0
0
63
459
1.39
1.71
3.1
3.3
223.49
43.01
u/ml
0.44
63
440
22
127
1.74
1.64
4.0
5.0
365.53
360.26
umol/l
0.06
17
106
1018
10523
0.86
1.56
4.8
4.4
1.37
1.45
mmol/l
6.27
929
9658
7
157
0.44
1.55
1.1
1.4
—
—
—
0
0
7
157
0.44
1.55
1.1
1.4
—
—
—
0
0
16
85
1.89
1.55
1.1
1.2
317.17
386.18
nmol/l
—
10
74
12
230
0.52
1.49
1.3
1.6
—
—
—
0
0
18
101
1.79
1.49
1.6
1.7
—
—
—
0
0
1027
10597
0.86
1.47
4.9
4.4
4.50
4.63
mmol/l
3.53
939
9784
342
3790
0.87
1.47
3.6
2.8
—
—
—
0
0
7
28
2.51
1.45
2.6
2.0
—
—
—
0
0
74
950
0.77
1.44
1.4
1.3
—
—
—
0
0
21
125
1.69
1.44
1.5
1.5
0.40
0.31
nmol/l
0.28
16
100
27
173
1.57
1.40
1.3
1.2
—
—
—
0
0
126
1044
1.23
1.37
8.4
3.7
—
—
—
0
0
6
23
2.62
1.37
1.7
1.2
—
—
—
0
0
8
163
0.49
1.36
1.1
1.5
—
—
—
0
0
17
284
0.59
1.34
1.1
1.2
—
—
—
0
0
32
216
1.49
1.34
1.2
1.3
—
—
—
0
0
926
8901
1.14
1.33
52.8
15.8
330.61
333.09
g/l
12.48
919
8830
8
34
2.36
1.29
4.1
2.4
16.95
279.66
ug/l
—
8
27
8
35
2.29
1.27
2.9
1.3
—
—
—
0
0
37
512
0.71
1.22
1.6
1.7
—
—
—
0
0
43
316
1.37
1.18
1.8
1.6
285.17
299.83
mu/l
0.12
36
290
1206
11849
1.21
1.16
60.3
18.0
91.87
90.99
fl
7.57
1196
11652
8
39
2.06
1.15
1.1
1.1
1837.63
1725.56
miu/ml
—
8
39
1206
11850
1.21
1.15
60.4
18.0
4.24
4.52
e12/l
49.90
1185
11487
1206
11853
1.21
1.13
60.9
18.1
127.48
136.68
g/l
62.66
1196
11654
1205
11845
1.21
1.11
60.7
18.1
241.61
246.02
e9/l
1.17
1185
11521
1205
11847
1.20
1.09
60.5
18.1
7.57
6.61
e9/l
10.69
1183
11486
5
21
2.39
1.09
3.2
2.9
284.00
542.24
u/l
—
5
21
32
227
1.42
1.08
3.4
1.6
1.30
0.77
nmol/l
1.05
26
188
1205
11849
1.20
1.07
60.2
18.0
30.41
30.37
pg
0.37
1195
11651
9
46
1.96
1.03
4.7
3.7
—
—
—
0
0
11
60
1.84
1.03
3.7
8.5
—
—
—
0
0
20
298
0.67
1.01
1.1
1.1
—
—
—
0
0
1203
11843
1.18
0.96
61.1
18.1
38.39
40.42
%
26.03
1127
11043
14
86
1.63
0.91
3.1
2.0
23.05
20.14
nmol/l
0.32
14
81
8
43
1.87
0.87
1.4
1.4
202.88
176.15
mmol/24h
—
8
43
11
64
1.72
0.86
1.0
1.0
—
—
—
0
0
8
44
1.82
0.86
1.1
1.0
—
10.81
—
0
10
24
170
1.42
0.85
1.0
1.1
0.94
128.47
iu/ml
—
5
45
104
893
1.18
0.85
1.4
1.4
—
—
—
0
0
1013
10363
0.90
0.84
5.2
4.5
6.07
5.94
mmol/l
1.81
929
9373
43
336
1.29
0.84
1.1
1.1
—
—
—
0
0
30
223
1.35
0.82
5.6
3.2
35.48
25.80
mg/l
0.65
23
133
8
48
1.67
0.78
2.3
2.5
0.32
1.21
ug/l
—
8
43
9
55
1.64
0.73
1.2
1.2
—
—
—
0
0
15
102
1.48
0.67
1.3
1.4
—
—
—
0
0
17
119
1.43
0.67
1.1
1.4
—
—
nmol/l
—
0
0
7
43
1.63
0.67
2.4
2.7
—
—
—
0
0
14
95
1.48
0.64
1.2
1.1
—
—
—
0
0
8
129
0.62
0.64
2.3
2.5
—
—
—
0
0
18
130
1.39
0.61
1.2
1.0
0.70
1.71
u/ml
0.76
11
65
17
123
1.39
0.58
1.1
1.4
—
—
—
0
0
18
132
1.37
0.57
1.0
1.0
1.85
2.45
u/ml
—
6
50
101
899
1.13
0.56
2.8
2.2
13.26
13.09
nmol/l
0.07
89
805
8
55
1.46
0.56
1.1
1.2
—
—
—
0
0
9
60
1.50
0.54
1.4
1.4
3.69
8.15
ug/l
—
9
49
20
151
1.33
0.54
1.2
1.1
2.09
2.70
u/ml
0.14
12
76
36
296
1.22
0.52
5.7
1.8
—
—
—
0
0
18
135
1.34
0.51
1.1
1.4
0.12
0.48
nmol/l
—
5
11
14
102
1.38
0.47
1.1
1.1
3.23
4.11
u/ml
—
7
36
52
448
1.17
0.47
2.1
2.7
—
—
—
0
0
19
148
1.29
0.43
1.3
1.2
—
—
—
0
0
5
32
1.56
0.42
3.0
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
2.0
—
3.25
—
0
8
18
142
1.27
0.38
1.2
1.0
3.88
7.51
u/ml
0.71
11
69
303
2897
1.06
0.38
1.8
1.6
1.58
1.38
mmol/l
3.10
256
2413
9
68
1.33
0.37
1.1
1.4
1.65
1.54
g/l
—
9
68
1003
10157
0.95
0.35
4.6
4.0
1.41
1.28
mmol/l
5.81
910
9250
17
136
1.25
0.33
1.2
1.1
0.38
2.56
u/ml
0.87
11
52
37
323
1.15
0.32
5.5
1.8
—
—
—
0
0
37
324
1.15
0.31
5.5
1.8
—
—
—
0
0
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
14
111
1.26
0.30
1.1
1.0
1.14
2.64
u/ml
—
8
51
27
231
1.17
0.30
2.6
1.9
229.33
215.28
pmol/l
0.18
27
216
36
409
0.88
0.29
1.0
1.1
—
—
—
0
0
37
326
1.14
0.29
5.5
1.7
—
—
—
0
0
110
1171
0.93
0.26
1.6
1.6
—
—
—
0
0
32
363
0.88
0.26
1.6
1.6
—
—
—
0
0
12
95
1.27
0.26
1.2
1.0
0.04
0.48
u/ml
—
7
28
36
320
1.13
0.25
5.7
1.8
—
—
—
0
0
10
78
1.28
0.24
2.0
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
10
80
1.25
0.20
1.9
1.5
86.10
80.28
umol/l
—
10
80
6
49
1.23
0.20
1.0
1.1
72.33
218.59
iu/ml
—
6
49
977
9853
0.97
0.19
7.2
5.7
40.63
39.64
mmol/mol
2.50
909
9099
32
352
0.91
0.18
17.6
9.1
—
—
—
0
0
83
789
1.06
0.16
1.2
1.2
—
—
—
0
0
9
80
1.13
0.15
1.4
1.4
142.11
173.87
pmol/l
—
9
80
63
663
0.95
0.13
1.2
1.2
—
—
—
0
0
23
209
1.10
0.13
8.1
2.5
—
—
—
0
0
27
250
1.08
0.11
7.0
1.9
—
—
—
0
0
23
249
0.92
0.10
1.3
1.8
1.32
5.17
iu/l
—
5
81
11
97
1.14
0.09
2.2
1.8
—
—
—
0
0
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
6
71
0.84
0.07
1.5
2.0
2.10
1.80
ug/l
—
6
62
10
89
1.12
0.07
1.0
1.1
—
—
—
0
0
422
4197
1.01
0.04
4.5
5.1
5.50
3.16
ug/l
0.37
379
3753
15
152
0.99
0.00
1.1
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
1184.40
—
0
5
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
5
52
0.96
0.00
1.0
1.5
—
—
—
0
0
8
87
0.92
0.00
1.1
1.0
328.63
284.96
mg/l
—
8
75
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
1.6
2.0
4.20
2.98
ug/l
—
7
65
5
49
1.02
-0.00
5.2
13.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint J10_PNEUMONONBACT and mortality.

Females

Parameter HR [95% CI] p-value
J10_PNEUMONONBACT 3.241 [2.53, 4.15] < 0.001
Birth year 0.999 [0.99, 1.01] 0.776

During the follow-up period (1.1.1998 — 31.12.2019), 589 out of 1540 females with J10_PNEUMONONBACT died.

Males

Parameter HR [95% CI] p-value
J10_PNEUMONONBACT 3.747 [2.93, 4.8] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 889 out of 1940 males with J10_PNEUMONONBACT died.

Mortality risk

Mortality risk for people of age

years, who have J10_PNEUMONONBACT.

N-year risk Females Males
1 0.373% 0.717%
5 2.086% 3.691%
10 5.952% 9.123%
15 10.65% 17.786%
20 18.24% 28.582%

Relationships between endpoints

Index endpoint: J10_PNEUMONONBACT – Pneumonia due to other infectious organisms, not elsewhere classified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data